Effects of liquisolid formulations on dissolution of naproxen.
about
Enhancement of Loperamide Dissolution Rate by Liquisolid Compact TechniqueModern evaluation of liquisolid systems with varying amounts of liquid phase prepared using two different methods.Preparation and characterization of liquisolid compacts for improved dissolution of telmisartanFormulation Development and evaluation of fast disintegrating tablets of Lamotrigine using liqui-solid techniqueIn vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.Enhancement of the Oral Bioavailability of Fexofenadine Hydrochloride via Cremophor(®) El-Based Liquisolid Tablets.Liquisolid technology for dissolution rate enhancement or sustained release.Drug release from liquisolid systems: speed it up, slow it down.Dissolution Enhancement of Rosuvastatin Calcium by Liquisolid Compact Technique.Liquisolid systems to improve the dissolution of furosemideEffect of hydrogen bond formation/replacement on solubility characteristics, gastric permeation and pharmacokinetics of curcumin by application of powder solution technology.Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.Design and Characterization of Buccoadhesive Liquisolid System of an Antihypertensive Drug.Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release.Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design.Formulation factors affecting the release of ezetimibe from different liquisolid compacts.Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis: development, optimization and in vitro/in vivo studies.Formulation and development of orodispersible sustained release tablet of domperidone.Comparative study of different approaches for preparation of chlorzoxazone orodispersible tablets.
P2860
Q28821517-7A4E3E1F-A703-4A48-A932-230AF4DC50D0Q30409303-FFB8028D-0D67-4BEE-B674-F66B100BE11FQ34413196-E210D649-8458-4A5F-A769-5333D6A884EDQ34562096-41D95912-8430-4D63-95B3-213EFC0B9F16Q35686923-D946D693-1A2B-46FF-A557-4B831838790EQ36509478-E41F904D-E918-4517-B406-D403F0B0BF88Q37781831-D4DC4A28-9FB2-457E-991A-F69850EA99D3Q37827494-316E4F1D-45B3-45C4-AE90-C44218A9DDE2Q40335951-5E7ED7DB-AD9E-4E91-A6E5-2A2AD95BA0F2Q41182158-BFE26CA6-DF6F-44F8-937F-6C842362EDD7Q41512316-D8296765-31E2-44C9-A9DD-EEE7A8E4800AQ41844498-99C9F59D-E134-4934-9205-B5474B261EE6Q41982108-61135217-DA75-4D94-9E17-4E6FC7120CA2Q41988444-EAC82C0F-6B03-47C1-9B55-A5808E5C58FAQ42975655-558A2EEF-B21C-4AD2-B48E-5275681C56FFQ44993507-C2CEF83C-56CB-4977-A72E-E093AF77BE90Q45259769-E00CD35C-48C2-44DD-9686-B18C103B8A39Q51684103-E8DC9EEB-63BF-4BCE-8CF6-E6CD8E414146Q53753879-925AC6E2-13A2-4071-B8B6-75B9BF052A73
P2860
Effects of liquisolid formulations on dissolution of naproxen.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Effects of liquisolid formulations on dissolution of naproxen.
@en
Effects of liquisolid formulations on dissolution of naproxen.
@nl
type
label
Effects of liquisolid formulations on dissolution of naproxen.
@en
Effects of liquisolid formulations on dissolution of naproxen.
@nl
prefLabel
Effects of liquisolid formulations on dissolution of naproxen.
@en
Effects of liquisolid formulations on dissolution of naproxen.
@nl
P1476
Effects of liquisolid formulations on dissolution of naproxen.
@en
P2093
Ngiik Tiong
P304
P356
10.1016/J.EJPB.2009.08.002
P407
P577
2009-08-11T00:00:00Z